Cerebral blood flow measured with 3D pseudocontinuous arterial spin-labeling MR imaging in alzheimer disease and mild cognitive impairment: A marker for disease severity

Radiology

Volumn 267, Issue 1, 2013, Pages 221-230

  Binnewijzend, Maja A A ^a   Kuijer, Joost P A ^a   Benedictus, Marije R ^a   Van Der Flier, Wiesje M ^a   Wink, Alle Meije ^a   Wattjes, Mike P ^a   Van Berckel, Bart N M ^a   Scheltens, Philip ^a   Barkhof, Frederik ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ALZHEIMER DISEASE; ARTERIAL SPIN LABELING; ARTICLE; BRAIN BLOOD FLOW; BRAIN MAPPING; COGNITION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; FEMALE; FUNCTIONAL ASSESSMENT; GENDER; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; IMAGE QUALITY; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SPIN LABELING;

AGED; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; CEREBROVASCULAR CIRCULATION; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; LINEAR MODELS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SPIN LABELS;

EID: 84875435187     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.12120928     Document Type: Article

References (29)

1. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 1991;82(4):239-259.
2. Sluimer JD, van der Flier WM, Karas GB, et al. Accelerating regional atrophy rates in the progression from normal aging to Alzheimer's disease. Eur Radiol 2009;19(12): 2826-2833.
3. Frisoni GB, Fox NC, Jack CR Jr, Scheltens P, Thompson PM. The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol 2010;6(2):67-77.
4. Jack CR Jr, Knopman DS, Jagust WJ, et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 2010;9(1):119-128.
5. Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 1997;42(1):85-94.
6. Ibáñez V, Pietrini P, Alexander GE, et al. Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease. Neurology 1998;50(6): 1585-1593.
7. Jueptner M, Weiller C. Review: does measurement of regional cerebral blood flow reflect synaptic activity? Implications for PET and fMRI. Neuroimage 1995;2(2): 148-156.
8. Alsop DC, Detre JA, Grossman M. Assessment of cerebral blood flow in Alzheimer's disease by spin-labeled magnetic resonance imaging. Ann Neurol 2000;47(1):93-100.
9. Chao LL, Pa J, Duarte A, et al. Patterns of cerebral hypoperfusion in amnestic and dysexecutive MCI. Alzheimer Dis Assoc Disord 2009;23(3):245-252.
10. Johnson NA, Jahng GH, Weiner MW, et al. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. Radiology 2005;234(3):851-859.
11. Xu G, Rowley HA, Wu G, et al. Reliability and precision of pseudo-continuous arterial spin labeling perfusion MRI on 3.0 T and comparison with 15O-water PET in elderly subjects at risk for Alzheimer's disease. NMR Biomed 2010;23(3):286-293.
12. Yoshiura T, Hiwatashi A, Noguchi T, et al. Arterial spin labelling at 3-T MR imaging for detection of individuals with Alzheimer's disease. Eur Radiol 2009; 19(12):2819-2825.
13. Mosconi L, Tsui WH, Herholz K, et al. Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias. J Nucl Med 2008;49(3):390-398.
14. Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001; 56(9):1133-1142.
15. Dai W, Garcia D, de Bazelaire C, Alsop DC. Continuous flow-driven inversion for arterial spin labeling using pulsed radio frequency and gradient fields. Magn Reson Med 2008;60(6):1488-1497.
16. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34(7): 939-944.
17. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004; 256(3):183-194.
18. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 1987; 149(2):351-356.
19. Buxton RB, Frank LR, Wong EC, Siewert B, Warach S, Edelman RR. A general kinetic model for quantitative perfusion imaging with arterial spin labeling. Magn Reson Med 1998;40(3):383-396.
20. Smith SM. Fast robust automated brain extraction. Hum Brain Mapp 2002;17(3): 143-155.
21. Jenkinson M, Smith S. A global optimisation method for robust affine registration of brain images. Med Image Anal 2001;5(2): 143-156.
22. Zhang Y, Brady M, Smith S. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging 2001;20(1):45-57.
23. Asllani I, Borogovac A, Brown TR. Regression algorithm correcting for partial volume effects in arterial spin labeling MRI. Magn Reson Med 2008;60(6):1362-1371.
24. Nichols TE, Holmes AP. Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum Brain Mapp 2002;15(1):1-25.
25. Smith SM, Nichols TE. Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage 2009;44(1):83-98.
26. Dai W, Lopez OL, Carmichael OT, Becker JT, Kuller LH, Gach HM. Mild cognitive impairment and Alzheimer disease: patterns of altered cerebral blood flow at MR imaging. Radiology 2009;250(3):856-866.
27. Chen Y, Wolk DA, Reddin JS, et al. Voxel-level comparison of arterial spinlabeled perfusion MRI and FDG-PET in Alzheimer disease. Neurology 2011;77(22): 1977-1985.
28. Alsop DC, Casement M, de Bazelaire C, Fong T, Press DZ. Hippocampal hyperperfusion in Alzheimer's disease. Neuroimage 2008;42(4):1267-1274.
29. Campbell AM, Beaulieu C. Pulsed arterial spin labeling parameter optimization for an elderly population. J Magn Reson Imaging 2006;23(3):398-403.